Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shokunbi, M. T.
Right arrow Articles by Miller, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shokunbi, M. T.
Right arrow Articles by Miller, D. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*LIDOCAINE

Stroke, Vol 21, 107-111, Copyright © 1990 by American Heart Association


ARTICLES

Continuous lidocaine infusion and focal feline cerebral ischemia

MT Shokunbi, AW Gelb, XM Wu and DJ Miller
Division of Neurosurgery, University of Western Ontario, London, Canada.

We measured somatosensory evoked potentials, infarct size, and cerebral blood flow in 20 cats subjected to occlusion of the middle cerebral artery for 3 hours, followed by an equal period of reperfusion. The cats were randomized into a treatment group that received a continuous infusion of 2 mg/kg lidocaine hydrochloride or a control group that received an equivalent volume of normal saline. All 10 treated cats retained measurable evoked potentials throughout the experiment. In five control cats, evoked potentials disappeared completely at some point during the occlusion (difference between groups significant at p less than 0.001). Mean amplitude of the major cortical wave in the nine treated cats with cerebral infarcts was higher than that of the nine corresponding controls (p less than 0.05). Lidocaine reduced the mean +/- SEM size of the infarcts from 30.1 +/- 6.0% in the control group to 14.7 +/- 4.9% in the treated group (p less than 0.05). As blood flow was reduced in the infarct and peri-infarct zones in the control but not the treated cats, our results suggest that the beneficial effects of lidocaine may be due to preservation of blood flow in the ischemic zone.


This article has been cited by other articles:


Home page
Br J AnaesthHome page
S. Fukuda and D. S. Warner
Cerebral protection
Br. J. Anaesth., July 1, 2007; 99(1): 10 - 17.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
H. Kinoshita, K. Nakahata, M. Dojo, Y. Kimoto, and Y. Hatano
Lidocaine Impairs Vasodilation Mediated by Adenosine Triphosphate-Sensitive K+ Channels but Not by Inward Rectifier K+ Channels in Rat Cerebral Microvessels
Anesth. Analg., September 1, 2004; 99(3): 904 - 909.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
K. M. Raley-Susman, I. S. Kass, J. E. Cottrell, R. B. Newman, G. Chambers, and J. Wang
Sodium Influx Blockade and Hypoxic Damage to CA1 Pyramidal Neurons in Rat Hippocampal Slices
J Neurophysiol, December 1, 2001; 86(6): 2715 - 2726.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
S. J. Mitchell, T. Willcox, F. Paget Milsom, and D. F. Gorman
Physical and Pharmacological Neuroprotection in Cardiac Surgery
Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 2000; 4(2): 80 - 85.
[Abstract] [PDF]